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Inflammation Mediates Body 
Weight and Ageing Effects on 
Psychomotor Slowing
Leonie J. T. Balter1,3*, Suzanne Higgs1, Sarah Aldred2, Jos A. Bosch3,4 & Jane E. Raymond  1,4
Inflammation (immune system activation) affects neuronal function and may have consequences for 
the efficiency and speed of functional brain processes. Indeed, unusually slow psychomotor speed, a 
measure predictive of behavioural performance and health outcomes, is found with obesity and ageing, 
two conditions also associated with chronic inflammation. Yet whether inflammation is the mediating 
factor remains unclear. Here, we assessed inflammation by indexing interleukin-6 level in blood and 
measured psychomotor speed as well as indices of selective visual attention in young (mean = 26 years) 
or old (mean = 71 years) adults (N = 83) who were either lean or currently significantly overweight 
(mean body mass index = 22.4 and 33.8, respectively). Inflammation was positively and significantly 
correlated with psychomotor speed, age, and body mass index but not with attention measures. Using 
mediation analyses we show for the first time that inflammation fully accounts for the significant 
psychomotor slowing found in those with high BMI. Moreover, we further show that age-related 
psychomotor slowing is partially mediated by inflammation. These findings support the proposal that 
reducing inflammation may mitigate weight- and age-related cognitive decline and thereby improve 
performance on daily tasks and health outcomes more generally.
Inflammation, a biological process that results from immune system activation, is a well-established character-
istic of advanced age1,2 and obesity3. At the cellular level, inflammation is known to cause neuronal dysfunction 
via alterations to microglia4–6, but how such alterations affect overt brain function remains less well studied. 
Nevertheless, emerging evidence tentatively links inflammatory states with subtle cognitive deficits, including 
slowed psychomotor speed, i.e., the minimum time required to make accurate, well-learned motor responses to 
obvious sensory stimuli7, slowed decision processes8, and memory deficits9,10, but see11; also12. Importantly, many 
of these same behavioural deficits are also found in individuals with obesity13,14 as well as in those in advanced 
age15. Taken together, the parallel relationships of both age and weight with cognitive function and inflammation 
raise the possibility that inflammation may be the underlying mechanism by which advanced age and excessive 
body weight lead to suboptimal cognitive capacity. Yet no study to date has examined how inflammation, age, and 
obesity interact to determine human cognitive performance using a participant sample that varies substantially 
on these dimensions. Not only does it remain unclear whether age and body weight are additive or multiplicative 
in their impact on performance, the hypothesis that inflammation may be the mediating mechanism remains 
untested.
A fundamental brain function that underpins many everyday activities is the capacity to respond rapidly and 
appropriately to new or changing visual information in a manner consistent with ongoing and future goals16. This 
requires appropriate selection of relevant information from the everchanging complex visual sensory environ-
ment, as well as the capacity to quickly activate appropriate motor responses as soon as cognitive decisions, e.g., 
object identification, have been reached. The former set of processes are known as selective visual attention17 and 
the latter as psychomotor speed (e.g.18). A typical example of the importance of these functions is fast braking in 
the face of a sudden, unexpected road obstacle. Selective attention directs processing towards the obstacle; psych-
omotor speed reflects the time needed to press the brake pedal. To efficiently select relevant information (targets) 
from a scene, discrete cognitive sub-functions subserved by different but overlapping brain networks are used19–22. 
One network function, Alerting, promotes selection by reacting to sensory cues that signal when a target might 
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appear; another, Orienting, reacts to cues signalling where a target might appear; and a third, Executive Control, 
promotes high level processing of task relevant information and suppresses processing of concurrent distracting 
information. Such functions can be assessed using the Attention Network Test (ANT) which requires participants 
to respond as quickly and accurately as possible to a series of simple computer-based trials, each comprised of a 
cue display that is quickly followed by a target array. See Fig. 1. The speed and accuracy of key press responses to 
targets are measured and compared across different cue-target conditions20–22. In addition to comprehensively 
assessing attention, this test provides a robust measure of psychomotor speed (overall mean response time, RT, 
across all cue conditions). Although psychomotor speed in everyday scenarios depends on the nature of the infor-
mation being presented and the complexity of the action decisions required23, its measurement when based on 
simple manual motor responses, such as required in the ANT, is nevertheless predictive of a range of performance 
outcomes, e.g., driving24, health outcomes, e.g., response to depression treatment25, and even mortality risk26.
Decline in attention and slowing of psychomotor speed has long been linked to ageing27 and has been 
well-studied using the ANT21,28–31. Such deficits are thought to contribute to frailty, risk of falling, depression, 
and poor health32–35. Several studies report weaker alerting benefits and/or diminished distractor suppression, 
an index of executive control29–32. However, after adjusting for the effects of generalised psychomotor slowing28, 
age-related attentional deficits disappear or become weaker28,29,36. Hence, ageing may have only modest effects on 
attention beyond generalised slowing, an issue we probe here.
The notion that age-related cognitive decline may be mediated by inflammation37,38 has received modest 
attention. Lin et al.8 for lean adults, inflammation only partially mediated the association between age and com-
plex cognitive processing speed and did not mediate links between age and short-term memory. Other studies 
show clear negative correlations between complex cognitive performance and inflammation in midlife9,39 and 
in older participants37, but did not conduct mediation analyses nor consider the role of body weight. Indeed, 
recent evidence provides strong support for the contention that age-related cognitive decline may be accelerated 
by excessive body weight, causing pre-senescent cognitive deficits38,40. A high BMI across the life span is asso-
ciated with lower performance across several cognitive domains that are characteristically degraded in ageing, 
including verbal memory41,42, executive functioning43–45 and, complex visual-motor coordination46. However, 
studies on the effects of excessive body weight on psychomotor slowing and selective visual attention are less 
clear. Some report weight-related deficits42,47,48, others find none40,49,50; one reported better performance with 
higher BMI51. Complicating this picture is evidence that depression and poor cardiovascular health, conditions 
that are co-morbid with obesity, may themselves contribute to reduced cognitive function52,53. Indeed, Prickett 
et al.14, reviewed findings that linked obesity with cognitive deficit and concluded that evidence was equivocal 
as to whether cognitive problems stem from obesity or from other co-morbid health and demographic factors. 
Nevertheless, using a very large sample of exclusively older adults and adjusting for other co-morbid factors in 
Figure 1. Experimental task design. The sequence of displays presented in each trial of the ANT task. The cue 
display had four equally likely conditions: no cue, spatial cue (80% valid), double cue, and centre cue. The target 
array comprised a central arrow and four identical flankers that were either congruent or incongruent with the 
target arrow. The task was to report the direction (up, down) of the centre target arrow as quickly and accurately 
as possible.
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a mediation analysis, Bourassa & Sbarra12 report support for a causal role of inflammation in weight-associated 
deficits on a delayed recall measure of memory.
Support for the possibility that inflammation may be a driving mechanism of psychomotor slowing is found in 
studies that acutely or experimentally induced inflammation and measured cognitive function with and without 
inflammation. For example, the common cold, a condition that produces an acute inflammatory response, leads to 
psychomotor slowing54,55 and translates to slower responses in a simulated driving task56,57. Experimentally induced 
inflammation via administration of immune-activating agents, such as bacterial endotoxin or vaccination, also 
causes psychomotor slowing7, memory deficits10 and alterations of social cognition58,59. However, the extant litera-
ture using experimental induction of inflammation so far provides little evidence of degraded selective attention60 
(reviewed in61), suggesting the possibility of domain-specificity in the inflammation-cognition link.
Taken together these findings support the notion that psychomotor slowing, shown clearly to be associated 
with advanced age and possibly with excessive body weight, may be mediated by chronic inflammation. The aim 
of the current study was to test this hypothesis by determining whether inflammation (as indexed by a generic 
marker of systemic inflammation; IL-6) is a mediator of age- and BMI-related psychomotor slowing. Additionally, 
we aimed to determine whether age and body weight are independent50,62 or interactive51 predictors of psycho-
motor speed and visual attention. We predicted that individuals with high BMI and advanced age would show 
higher levels of inflammation and slower psychomotor speed compared to their leaner and younger counterparts. 
The association between BMI, age, and psychomotor speed was expected to be at least partially mediated by 
inflammation. Furthermore, attentional processing was not expected to be reduced by either older age or high 
BMI when psychomotor speed was taken into account (e.g.29).
Results
Inflammation. The study was conducted on four participant groups who differed in age (young, old) and 
BMI (low, high), but not in education level. The sample characteristics are presented in Table 1. To assess the 
effects of age and BMI on inflammation, an analysis of variance (ANOVA) was conducted on IL-6. Confirming 
expectations, IL-6 levels were higher in the high versus low BMI groups (F(1, 79) = 49.25, p < 0.001, ηp2 = 0.37), 
and also higher in the old versus young groups (F(1, 79) = 4.55, p = 0.036, ηp2 = 0.03). The interaction of age and 
BMI was non-significant (F(1, 79) = 1.62, p = 0.207, ηp2 = 0.01). Mutual adjustment (i.e., BMI adjusted for age 
(F(1, 80) = 49.00, p < 0.001, ηp2 = 0.38), and age adjusted for BMI (F(1, 80) = 4.06, p = 0.047, ηp2 = 0.05) yielded 
a comparable pattern of results. IL-6 significantly correlated with BMI (rS(81) = 0.655, p < 0.001) and with age 
(rS(81) = 0.320, p = 0.003). See Fig. 2a.
Behavioural measures. The ANT task was used to measure psychomotor speed (overall RT computed 
using all task conditions) and visual attention. Participants were shown one of four warning cues followed by a 
target arrow flanked by four similar arrows pointing in the same (congruent) or opposite (incongruent) direction 
as the target arrow. As illustrated in Fig. 1, the participant’s task was to report the direction of the central target 
as quickly and accurately as possible. The four different warning cue conditions were: (1) no cue, (2) double 
alerting cue (one cue appearing simultaneously at each possible target location), (3) central alerting cue (appear-
ing in place of the fixation cross), and (4) spatial cue (a single cue appearing at one of the two possible target 
locations). The spatial cue predicted the target location correctly on 80% of trials (valid trials) and incorrectly 
on 20% of trials (invalid trials). Differences in RT for the different cue and target-flanker conditions were used 
to index the efficiency of separate components of attention in each individual. As is conventional21, the alert-
ing network was assessed by comparing performance on double-cue versus no-cue trials; the orienting network 
was assessed by comparing performance on valid spatial cue trials versus double-cue trials; validity effects were 
indexed by comparing performance on valid versus invalid spatial cue trials; and lastly, the executive control 
network was assessed by differences in performance for congruent versus incongruent flanker trials, regardless 
of cue condition.
ANOVA of individual condition mean RTs obtained in the ANT task revealed main effects of Age group (F(1, 
79) = 68.36, p < 0.001, ηp2 = 0.46), BMI group (F(1, 79) = 6.62, p = 0.012, ηp2 = 0.08), Target Flanker condition 
(F(1, 79) = 89.42, p < 0.001, ηp2 = 0.53), and Cue condition,(F(4, 316) = 20.08, p < 0.001, ηp2 = 0.20). As expected 
the interaction of Cue X Target Flanker condition was also significant (F(4, 316) = 2.69, p = 0.031, ηp2 = 0.03), but 
neither this effect nor any other effect of target flanker or cue condition interacted with Age or BMI group (all 
F’s < 1.2). Critically, Age and BMI group did not significantly interact (F(1, 79) = 0.68, p = 0.412, ηp2 = 0.01). The 
group mean RTs and accuracy for each target flanker and warning cue condition for each age and BMI group are 
shown in Tables 2 and 3.
Psychomotor speed (overall RT). Main effects of Age and BMI describe group effects on psychomotor 
slowing (overall RT), a point of primary interest for the current study, and therefore merit further examination. 
Contrasting with some previous studies40, we found that individuals with high BMI were 53 ms (s.e. = 20 ms) 
slower than lean individuals (adjusted for age: F(1, 79) = 6.90, p = 0.010, ηp2 = 0.08) and that BMI was positively 
correlated with overall RT (rS(81) = 0.334, p = 0.002). See Fig. 2b. Confirming previous reports27, psychomotor 
speed for older adults was on average 169 ms (s.e. = 20 ms) slower than that for young adults (adjusted for weight: 
F(1, 79) = 70.98, p < 0.001, ηp2 = 0.47) and age and overall RT were highly correlated (rS(81) = 0.659, p < 0.001) 
(see Fig. 2). Adjustments for relevant demographic and health-related variables listed in Table 1 did not alter any 
of these results related to psychomotor speed or attention (all F’s < 1). Additionally, body fat percentage (BF%) 
and BMI were highly correlated in the current sample (males r(48) = 0.902, p < 0.001; females r(33) = 0.860, 
p < 0.001), suggesting that BF% and BMI measure similar aspects of body mass. Moreover, the correlation 
between BMI and RT (rs(81) = 0.334, p = 0.002) and BF% and RT were very similar (rs(81) = 0.360, p < 0.001).
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As shown in Table 3, accuracy across all groups was high (M = 97.7%, s.e. = 0.3%), although accuracy was 1.8 
percentage points better for old versus young participants (F(1, 78) = 20.52, p = 0.002, ηp2 = 0.12), suggesting that 
speed accuracy trade-offs may have contributed to age-related slowing. Accuracy did not differ between the two 
BMI groups (F < 1).
As shown in Fig. 3a–d, psychomotor speed was significantly correlated with inflammation for the low 
(rS(40) = 0.304, p = 0.047) and high BMI (rS(43) = 0.422, p = 0.007) groups; a similar effect was also found for the 
young group (rS(38) = 0.612, p < 0.001) but was absent in the old group (rS(45) = 0.179, p = 0.238). This supports 
the idea that performance in ageing is affected by multiple factors. To investigate the hypothesis that inflamma-
tion mediated the relationship between overall RT and either BMI or age, mediation analyses were performed on 
overall RT scores. As shown in Fig. 3e, when IL-6 was entered as a mediating variable, BMI group was no longer a 
significant predictor of RT (β = 0.00, 95% CI = −0.26–0.25) indicating that inflammation level fully mediated the 
relationship between BMI and RT (β = 0.26, 95% CI = 0.09–0.46). As a further test, individuals were divided into 
Characteristic
Young Low 
BMI
Young High 
BMI
Old Low 
BMI
Old High 
BMI
Main effects
Age BMI
N 20 18 20 25
Age (years)
  Mean 24.9 27.3 72.2 69.5 Age***
  Range 21–32 21–35 66–79 63–76
Sex (% Female) 45 39 40 40
IL-6 (pg/ml) 1.04 (0.44) 2.13 (0.67) 1.44 (0.61) 2.32 (1.01) Age* BMI***
  Range 0.3–2.1 1.1–6.0 0.8–3.2 1.1–6.0
Weight Status
  BMI (kg/m2) 21.7 (2.5) 33.2 (3.7) 23.1 (1.8) 32.5 (3.9) BMI***
  BMI when young (21–35) (kg/m2) 21.8 (1.6) 25.9 (4.5)
Body fat %
  Females 27.9 (3.9) 45.3 (4.8) 33.6 (5.8) 44.9 (4.8) BMI***
  Males 15.7 (4.4) 28.9 (3.8) 22.4 (5.0) 31.6 (5.1) BMI***
Time of day tested (start time) 11h34(1h45)
11h16
(1h27)
11h31
(1h51)
11h22
(1h15)
Education level %
  Higher 100 72 75 72
  Middle 0 17 25 28
  Lower 0 11 0 0
Self-reported health (scale 1–10) 8.4 (0.9) 7.6 (1.4) 8.7 (0.9) 8.0 (1.2) BMI***
Illness symptoms (SCQ) 0.7 (1.0) 1.3 (2.0) 2.7 (2.0) 4.9 (3.2) Age*** BMI**
History of illness symptoms (SCQ) 2 (1.7) 2.6 (3.2)
Sum of medication 0.1 (0.3) 0 (0) 0.9 (1.4) 1.7 (1.6) Age**
  Range 0–1 0–1 0–4 0–5
Occupation status^%
  Employed 10 22 10 0
  Student 90 50 0 0 Age*** BMI*
  Retired 0 0 85 100 Age***
  Voluntary work 0 0 10 20 Age*
  Unemployed 0 28 5 0
Smoking %
  Current smoker 0 6 0 0
  Ex-smoker 5 18 25 44 Age*
  Never smoker 95 76 75 56 BMI**
  Alcohol intake in units 1.6 (3.3) 1.7 (3.3) 6.3 (4.5) 7.7 (10.2) Age***
Emotional health
  Depression 4.7 (6.1) 7.4 (7.5) 1.1 (2.0) 2.8 (3.7) Age***
  Anxiety 4.7 (5.0) 6.0 (5.8) 0.6 (1.3) 1.5 (2.0) Age***
  Stress 10.3 (7.5) 10.4 (7.0) 4.8 (4.5) 5 (4.8) Age***
  Loneliness 37.2 (7.9) 37.4 (7.5) 35.3 (6.0) 36.5 (6.5)
Table 1. Descriptive statistics of participant characteristics. Numbers in parenthesis indicate s.d.; Statistical 
significance of main effects are indicated as follows; *p < 0.05, **p < 0.01, ***p < 0.001. All interactions 
involving Age or BMI group were non-significant; ^Please note that percentage may add up to more than 100% 
due to multiple answer possibilities.
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two groups based solely on inflammation level (using a median split), and the group’s overall RTs were compared. 
The high inflammation group was on average 90 ms (s.e. = 2.7 ms) slower compared to the low inflammation 
group (t(81) = −3.40, p = 0.001; d = − 0.747, independent 2-tailed).
The mediation analysis also showed a significant indirect effect of inflammation on the association between 
age and overall RT (β = 0.06, 95% CI = 0.01–0.15). However, age remained a significant predictor of RT after 
accounting for the mediating effect of IL-6 (β = 0.62, 95% CI = 0.46–0.77), indicating that IL-6 only partially 
mediated the effect of age on RT (see Fig. 3f). Adjusting for sex, education level, time of day, perceived health 
status, depression, anxiety, stress, illness symptoms, smoking status, and alcohol intake and repeating the above 
Figure 2. Correlations of BMI with IL-6 and psychomotor speed (RT), and RT differences between groups. 
(a) Individual Log IL-6 level or (b) psychomotor speed plotted as a function of BMI. Each dot represents a 
single participant and dot gray scale reflects the participant’s age. Log IL-6 significantly correlated with BMI 
(rS(81) = 0.655, p < 0.001) and Age (rS(81) = 0.320, p = 0.003). Overall RT significantly correlated with BMI 
(rS(81) = 0.334, p = 0.002) and Age (rS(81) = 0.659, p < 0.001) (c). Mean psychomotor speed for each group. 
Error bars represent standard error of the mean (s.e.).
Target Flanker condition Warning Cue condition
Congruent Incongruent No Centre Double Valid Invalid
Mean-
RT
Young
Low BMI
490
(11)
550
(14)
524
(12)
519
(11)
523
(14)
502
(12)
552
(17)
518
(12)
Young
High BMI
556
(18)
625
(31)
601
(22)
591
(24)
602
(29) 571 (26)
606
(19)
590
(25)
Old
Low BMI
678
(15)
740
(29)
708
(17)
705
(25)
723
(20) 693 (19)
734
(23)
708
(20)
Old
High BMI
707
(21)
778
(23)
749
(22)
739
(21)
753
(22) 722 (21)
787
(33)
742
(21)
Table 2. Mean RTs (s.e.) as a function of target flanker condition and warning cue condition for each Age and 
BMI group.
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mediation analyses using hierarchical regression analysis did not significantly alter results (see Supplementary 
information Tables S1 and S2).
Visual attention. Results of the main ANOVA showed only main effects of Age and BMI group on RT. 
Although neither Age nor BMI group significantly interacted with cue or target flanker condition, we redid the 
analysis using Z-transformed RT data29 to assess age, BMI, and inflammation effects on visual attention, inde-
pendently of psychomotor slowing (RT) (see the Statistical methods).
The group mean Z-scores for each network comparison are shown in Table 4. Analyses revealed that alerting 
(double) cues enhanced performance relative to the no cue condition more in young (M = 0.14, s.e. = 0.17) than 
in old (M = −0.40, s.e. = 0.15) adults (F(1, 79) = 5.73, p = 0.019, ηp2 = 0.07). Young adults were more distracted by 
incongruent trials (M = 2.30, s.e. = 0.15) compared to old adults (M = 1.80, s.e. = 0.14; F(1, 79) = 6.44, p = 0.013, 
ηp2 = 0.08). No significant age effects were observed for orienting or validity measures (F’s < 1). Effects of BMI on 
all attention measure were non-significant (F’s < 1, except for Conflicting, F = 1.53, p = 0.220). Furthermore, no 
correlation between any network measure and IL-6 reached significance (p’s > 0.5). Hence, no further analyses 
were performed to test possible mediating effects of IL-6.
Bayesian correlation analyses showed moderate evidence for H0 for a correlation between IL-6 and Z-score 
alerting (BF10 = 0.16), orienting (BF10 = 0.17), executive control (BF10 = 0.14) and validity effects (BF10 = 0.14). 
Furthermore, Bayesian ANOVAs showed moderate evidence for the null hypothesis (H0) against the alternative 
hypothesis (HA) for Z-scores alerting (BMI BF10 = 0.32), orienting (BMI BF10 = 0.25; ageing BF10 = 0.29), and 
validity (BMI BF10 = 0.24) and anecdotal evidence for the H0 for executive control in BMI (BF10 = 0.47) and 
validity effect in ageing (BF10 = 0.36). The significant effect between age and alerting was supported by Bayesian 
ANOVA showing moderate evidence for the HA (BF10 = 3.10). Anecdotal evidence was found for the age effect on 
executive control (BF10 = 2.42).
Discussion
The current study examined the relative contributions of inflammation, body weight, and ageing to psychomo-
tor speed and visual attentional processing. As inflammation has been implicated as a putative mechanism for 
both ageing and BMI associated cognitive decline, the current analyses examined whether these associations, 
if present, were mediated by inflammation. Although our results confirm earlier findings showing that age and 
BMI are each associated with psychomotor slowing and inflammation, we show here, for the first time, that 
inflammation fully mediates BMI-related psychomotor slowing (regardless of age) and that inflammation only 
partially mediates age-related psychomotor slowing (regardless of body weight). These results partly explain why 
studies show conflicting results between BMI and psychomotor speed (e.g.40,42), since it is not BMI but rather 
the level of inflammation that is predictive of psychomotor speed. Our results further show that inflammation 
partially accounts for age-related psychomotor slowing. With regard to visual attention processes, our results 
show reduced performance benefits of alerting cues (“alerting”) in older adults (after adjusting for psychomotor 
speed), yet intact, efficient use of spatial information (“orienting”) (e.g.28,29,63,64). No relationships were observed 
between visual attention measures and BMI or inflammation. Together, these results strongly support the con-
tention that inflammation is a significant biological predictor of psychomotor slowing, especially in individuals 
with high BMI.
A putative pathway by which inflammation might exert cognitive effects is through modulating dopamine 
pathways65. The nigrostriatal dopamine pathway is pivotal in the facilitation of movement, signalling stimulus 
salience, and motivated behaviours, and it has been demonstrated that inflammation modulates this system7,65. 
Consistent with this speculation, lower levels of striatal dopamine transporter are associated with psychomotor 
slowing in healthy older adults66 and altered function of the dopamine system in individuals with obesity has 
also been reported67. Dopamine function may possibly be altered, directly or indirectly, via microglia. Activated 
microglia, the brain’s most prominent immune cells, have the capacity to significantly interfere with synaptic 
turnover, architecture, and function68. The substania nigra has a very high density of microglia69–71 and activating 
nigral microglia, for example via local injection of lipopolysaccharides, results in permanent and selective deple-
tion of nigral dopamine72. Further indirect support for a role of activated microglia in inflammation-associated 
psychomotor slowing in humans is the finding that induced acute inflammation in humans, via injection of 
typhoid vaccination, altered the functional integrity of the microglial-rich substania nigra and was accompanied 
by psychomotor slowing7. Furthermore, in ageing and obesity as well as in certain neurodegenerative conditions, 
Target Flanker condition Warning Cue condition
Congruent Incongruent No Centre Double Valid Invalid
Mean-
%
Young
Low BMI
98.1
(0.6)
93.8
(1.5)
95.9
(1.4)
95.5
(1.1)
95.6
(1.1)
96.7
(0.9)
94.7
(2.1)
95.9
(1.0)
Young
High BMI
98.6
(0.4)
94.8
(1.3)
96.9
(1.0)
96.3
(1.1)
95.8
(1.1)
97.4
(0.6)
96.5
(1.4)
96.7
(0.8)
Old
Low BMI
99.0
(0.3)
97.7
(0.8)
98.1
(0.9)
98.0
(0.5)
98.5
(0.6)
98.6
(0.4)
98.1
(0.7)
98.3
(0.4)
Old
High BMI
99.0
(0.4)
98.1
(0.6)
98.1
(0.7)
99.0
(0.4)
98.6
(0.5)
98.9
(0.5)
97.5
(1.0)
98.6
(0.4)
Table 3. Mean accuracy scores in % (s.e.) as a function of target flanker condition and warning cue condition 
for each Age and BMI group.
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e.g., Alzheimer’s and Parkinson’s disease, microglia shift from a state of relative quiescence to one of activation73,74. 
This results in an enhanced inflammatory response that in turn promotes neural damage and leads to cogni-
tive degradation4,75. It is tempting to speculate that disturbance of these functions within brain regions that are 
involved in psychomotor speed may represent an etiological factor in the onset or progression of psychomotor 
slowing in inflammatory states. However, considering that age-related psychomotor slowing is not fully explained 
by elevated inflammation, other mechanisms that are not directly related to inflammation, such as synaptic alter-
ations, white matter lesions, oxidative damage, hormonal changes, and neurochemical changes (e.g.76,77) may 
contribute to psychomotor slowing in advanced age. Moreover, it remains to be determined how peripherally 
produced inflammatory mediators communicate with the brain to exert its effects on these aforementioned struc-
tures and systems. Candidate mechanisms via which cytokines can access the brain include dysfunction of the 
blood brain barrier (BBB), leaky sections in the circumventricular organs, and retrograde transport via afferent 
Figure 3. Spearman’s correlations between IL-6 and psychomotor speed (RT), and standardised regression 
coefficients of the mediation analyses. Spearman’s correlations between IL-6 levels and psychomotor speed 
(RT) in the low BMI (a), high BMI (b), young (c), and old (d) groups. Standardised regression coefficients 
of the mediation analyses for the BMI and age groups are shown in (e,f), respectively. Age and BMI group 
significantly predicted RT and IL-6 level. IL-6 level still significantly predicted RT once the effect of BMI/Age on 
RT was taken into account. However, the effect between BMI and RT became non-significant after accounting 
for differences in IL-6, suggesting that IL-6 fully mediates the effect between BMI and RT. The effect between 
Age and RT became weaker but remained significant after taking into account IL-6, suggesting that IL-6 (only) 
partly mediates the effect of Age on RT. Indirect effects after taking mediation into account are presented in 
parentheses. *p < 0.05, **p < 0.01, ***p < 0.001.
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nerves such as the vagus nerve (reviewed in78). The current findings are in support of the proposal that reducing 
inflammation may be useful for mitigating age-related cognitive impairment79, and, as suggested by the current 
data, this benefit may be particularly relevant to individuals with a high BMI. Since psychomotor demands under-
lie the performance of many routine activities, such as using motorised vehicles, counting out change, and social 
discourse, means to improve psychomotor speed or delay its age-related degradation are critically. Factors that 
may partially ameliorate inflammation include modifiable health behaviours such as body weight reduction and 
improvement of lifestyle (e.g., better diet, more physical activity)80,81. Lifestyle adjustments that decrease inflam-
mation may improve cognitive and emotional processes that in turn enhance the ability to engage in and adhere 
to such lifestyle changes. Not only might this further support a positive cycle of improved health behaviours, such 
lifestyle adjustments are also relevant to healthy ageing, by reducing risk of diabetes, cardiovascular diseases, and 
depression82,83.
Despite the fact that being overweight or obese is recognised as a major risk factor in the development of 
health issues and cognitive decline, there is an ongoing debate about possible protective effects of being over-
weight or obese in old age, referred to as the “obesity paradox”. The obesity paradox has mostly been described 
in terms of advantageous effects of being overweight or obese for chronic diseases and health outcomes such as 
coronary heart disease, stroke, high blood pressure, and osteoporosis84,85, and has more recently been extended to 
cognitive processes. The literature on the obesity paradox for cognition is less straightforward compared to that 
for cardiovascular-associated conditions. Whereas some studies report that higher BMI in midlife is associated 
with greater cognitive decline in late life13,86,87, others report that high mid-life BMI is predictive of better cogni-
tive performance in late life (e.g.51,88,) or is non-predictive43. These contrasting observations expose the need for 
greater research in this area and for the development of clarity on mechanisms by which high mid-life BMI might 
affect central nervous system ageing89. Although not longitudinal in design, the current study points towards neg-
ative cognitive effects of high BMI-associated inflammation across adulthood, thus arguing against the possibility 
of cognitive benefits bestowed via the obesity paradox.
The present study has several limitations that warrant consideration. First, the data is correlational in nature. 
Experimental studies that test whether lowering inflammation, for example through reducing fat mass, restores 
psychomotor speed may be able to assess a causal role of inflammation and specific mediators. Likewise, it 
remains to be determined whether chronic inflammation results in permanent disruption of psychomotor func-
tions or whether effects can be restored when inflammation resolves. Lastly, IL-6 was used as a generic index of 
inflammation but no causal assumptions about the role of IL-6 in the observed effects can be made. Future studies 
may perhaps incorporate additional markers that may have a proximal role in the effects observed here. At cur-
rent it is not known which these might be.
In sum, the present study showed that individual differences in psychomotor speed can be accounted for 
by elevated inflammation linked to being either excessively overweight or older, with effects of each condition 
being additive, not interactive. Further research focusing on central pathways may help enhance mechanistic 
understanding of inflammatory effects on cognition. This and other experimental work could help more firmly 
establish a causal role of inflammation in determining psychomotor speed and reveal whether periods of chronic 
inflammation result in temporary versus permanent psychomotor slowing.
Method
Participants. Eighty-nine participants with a BMI (weight(kg)/height(m)2) between 17 and 25 (low BMI) 
or greater than 27 (high BMI) and aged between 21 and 35 years (young) or between 63 and 80 years (old) were 
recruited through a database held by the University of Birmingham and via (online) advertisements. Individuals 
who reported a history of gastric banding, eating disorders, neurological or inflammatory disorders (e.g., rheu-
matoid arthritis, inflammatory bowel disease, multiple sclerosis, periodontitis) or use of anti-depressant, anti-his-
tamine, or anti-inflammatory (e.g., antibiotics) medication during the past 7 days were excluded. Participants 
reported normal or corrected-to-normal vision and stable body weight for at least six months (i.e., fluctuations 
<7.5 kg for individuals with high BMI, <5 kg for low BMI individuals). All data from 6 individuals were excluded 
from all analyses as their overall behavioural accuracy was on worse than 2.5 s.d.’s below the group average (N = 2) 
or because their overall RT was identified by Cook’s distance as being influential (N = 4). Table 1 shows descrip-
tive statistics of the remaining participants’ characteristics. Power analysis calculated using a power of 0.8 and an 
alpha of 0.05 suggests that a total sample size of 74 is adequate to detect medium to large effect sizes (d = 0.6)32,39. 
The study was conducted according to the guidelines laid down in the Declaration of Helsinki and all procedures 
were approved by the University of Birmingham Research Ethics Committee.
Procedures. Test sessions started between 8:30 and 15:30 hours. Start times of test sessions were matched 
across groups to control for minor diurnal variations in IL-690. However, such variations were not observed in 
the current study (Spearman’s correlation of IL-6 and time of day (rS(81) = 0.044, p = 0.696). Participants were 
instructed to have breakfast/lunch as usual but avoid consumption of high-fat products (e.g., bacon, fries), 
Alerting Orienting Conflicting Validity
Young Low BMI 0.09 (0.24) 0.76 (0.21) 2.31 (0.21) 1.63 (0.28)
Young High BMI 0.24 (0.24) 1.01 (0.22) 2.30 (0.21) 1.39 (0.28)
Old Low BMI −0.50 (0.23) 1.17 (0.21) 1.54 (0.20) 1.27 (0.27)
Old High BMI −0.30 (0.21) 0.93 (0.19) 2.10 (0.18) 1.35 (0.24)
Table 4. Mean Z-score transformed RT attention network scores (s.e.) shown for each Age and BMI group.
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because these foods may induce a short-lived inflammatory response91, and to refrain from eating, drinking 
(except for water), and smoking for 1 hour before the start of the test session. Participants were also asked not to 
engage in strenuous physical exercise or consume alcohol within 12 hours before the test session, and reschedule 
their appointment if they had suspected infection symptoms on the day of testing. On arrival, written informed 
consent was obtained and it was verified via self-report whether all had complied with instructions. A blood 
sample was taken by venipuncture and questionnaires and cognitive tests including the ANT were completed 
(see further below). Other tests included measures of memory, reward-based learning, and emotion recognition 
(results not reported here). Lastly, a measure of height and body composition was taken.
Materials
Questionnaires were completed on a touch screen tablet. A desktop running PsychoPy v1.83.0192 was used to 
record data and present cognitive tests including the ANT.
Attention network test. Stimuli. A fixation cross (1° of visual angle in diameter) was continuously pres-
ent at the screen’s centre. Warning cues comprised one or two asterisks, each 0.6° in diameter, that appeared 
either 2.3° left and/or right of the central fixation cross. The test display comprised of a vertical row of five arrows 
centred horizontally within the screen and appearing either 2.3° left or right of the fixation. The entire row of 
arrows subtended 3.3° of visual angle; each individual arrow was identical in size (0.6° tall × 1.7° wide) with the 
space between each being 0.1°. Each arrow could point up or down. In all conditions, the target stimulus was the 
middle arrow. The two arrows appearing above and below the target (flankers; four in total) always had the same 
orientation but this could differ from the orientation of the target.
Procedure. Each trial began with one of four different warning cues (asterisks; (1) no cue, (2) double cue, (3) 
central alerting cue, (4) spatial cue), each lasting 100 ms. Regardless of warning cue condition, the cue’s offset 
preceded the target display by a variable and randomly determined interval of 500‒1000 ms. This display com-
prised the target and flanker arrows; it disappeared immediately upon response or within 2000 ms. The partici-
pant’s task was to indicate the direction of the arrow in the centre of the target display by pressing a corresponding 
key on the keyboard using the index and middle finger of the dominant hand as quickly and accurately as pos-
sible. Response time (RT) was defined as the interval between the onset of the arrow display and the associated 
keyboard response (in ms). There were 50 trials per participant per warning cue condition; half of all trials per 
warning cue condition had congruent flankers and half had incongruent flankers. For the spatial cue condition, 
80% of trial were valid, 20% invalid.
Every combination of target orientation (up/down) and location (left/right) and distractor compatibility (con-
gruent, incongruent) was equally likely for each warning cue condition. The order of all the various trial types 
was pseudo-randomly determined for each participant. Participants performed one practice block of 15 trials 
followed by one experimental block of 200 trials.
Blood sampling. Blood was collected into one 6 ml vacutainer containing EDTA as anticoagulant (Becton 
Dickinson Diagnostics, Oxford, United Kingdom). Samples were immediately centrifuged at 1500 x g for 10 min 
at 4 °C and plasma was aliquoted and stored at −80 °C for later assessment of IL-6, a generic marker of systemic 
inflammation. Plasma level of IL-6 was measured in duplicate using high-sensitivity enzyme-linked immuno-
sorbent assay (ELISA) (Quantikine HS Human IL-6 ELISA, R&D Systems, UK) in accordance with the manufac-
turer’s instructions. In brief, standards and diluted experimental samples were transferred to a 96-well microplate 
pre-coated with a monoclonal antibody specific for human IL-6. The IL-6 present was bound by the immobilized 
antibody. After washing away the unbound substances, the enzyme-linked polyclonal antibody was added to the 
wells. Following a wash to remove any unbound antibody enzyme reagent, the substrate solution (lyophilized 
NADPH with stabilizers) was added to the wells. Upon incubation with the experimental samples for 120 min, 
the amplifier solution (lyophilized amplifier enzymes with stabilizers) was added to the wells for visualization. 
Readings were subsequently performed using a microplate reader. Data were expressed as pg/mL. The limit of 
detection of these assays was 0.11 pg/mL, with intra- and interassay coefficients of variation (CVs) of 0.7‒11.6%. 
IL-6 was used as the primary generic index of inflammation and no causal assumptions about the role of IL-6 in 
the observed effects are made. No other inflammatory markers were assessed.
Questionnaires and anthropomorphic measures. Participants completed health and demographic question-
naires for two reasons. Firstly, to describe the groups and secondly, to adjust for health and demographic factors 
previously shown to be associated with inflammation, i.e., illness symptoms (Self-Administered Comorbidity 
Questionnaire (SCQ)93, depression, anxiety and stress (Depression Anxiety and Stress-21 (DASS-21)94), loneliness 
(UCLA Loneliness Scale95) and demographic variables, i.e., age, education level (low-, middle-, high-educated), 
perceived health status (rated from ‘1 very poor’ to ‘10 excellent’), alcohol intake (units per week), and smoking 
status (never-, ex-, current-smoker).
Statistical analysis. RT data. As is conventional (e.g.21), RTs were excluded from the statistical analyses 
if the response was incorrect or too fast (RT < 150 ms), accounting for 3.6% of the data. Also excluded were data 
from participants who disproportionally bias mean estimates (N = 4; using Cook’s distance, 2 young high BMI, 1 
old low BMI, 1 old high BMI) and those who had accuracy scores 2.5 s.d.’s lower than the mean (N = 2; 2 young 
high BMI), indicative of poor engagement or inadequate understanding of the task. Individual condition mean 
RTs and accuracy scores were then subjected to a mixed design repeated measures ANOVA using cue condition 
(no, double, valid, invalid, and centre cue) and target flanker (congruent and incongruent) as within-subjects 
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factor and Age group and BMI group as between-subjects factors. Psychomotor speed (overall RT) data were 
then analysed using ANCOVA with age group and BMI group as between-subjects factors and mutual adjust-
ment for age and BMI was applied (i.e., BMI adjusted for age, and age adjusted for BMI). For these analyses and 
all subsequent analyses where appropriate, Levene’s test of Equality of Variances and Mauchly’s Test of Sphericity 
were used to test for assumption violations; adjustments were made as needed using the Greenhouse-Geisser 
correction. Spearman correlations were used to test relationships between age, BMI, IL-6 and RT. Alpha values 
were set at 0.05 throughout. All analyses were conducted using SPSS v.24.0 (IBM-SPSS Inc., Chicago, IL, USA).
To assess effects of age, BMI and inflammation on attention independent of psychomotor slowing, RT cue 
and target flanker conditions were z-score transformed by taking the individual’s mean score for the condition of 
interest (e.g., RT double cue trials), subtracting his/her grand average (of all cue and target flanker conditions), 
and dividing this difference by the standard deviation associated with his/her grand average.
In addition to traditional null hypothesis significance testing, Bayes Factors were calculated for non-significant 
effects via Bayesian ANOVA using default prior probabilities in JASP version 0.9. Non-significant effects can be 
the result of absence of differences or because of a lack of statistical power to detect differences. Bayesian analyses 
can be used to distinguish between these two options96. Bayes factors provide relative evidence of both null (H0) 
and alternative hypotheses (HA), compared to the conclusions about the null hypothesis proffered by traditional 
null hypothesis significance testing. To allow for clear interpretation, the approximate classification scheme of97 
was used which states that an estimated Bayes Factor (BF10; H0/HA) value <1 supports evidence in favour of the 
H0. For example, a BF10 of 0.25 indicates that the H0 is 4 times (1:0.25) more likely than the HA. Values close to 
1 are not informative and a BF10 between 1 and 3 provides anecdotal evidence for the HA. A BF10 between 1 and 
0.33 provides anecdotal evidence for the H0 (e.g., 1:3 probability in favour of H0) and a BF10 between 0.33 and 0.10 
provides moderate evidence for H0. A BF10 < 0.10 provides strong evidence for H0.
Mediation effects. PROCESS software98 was used to test mediation effects of inflammation (Model 4 with 5000 
bootstrap samples). Cook’s distance was used to identify influential data points, which disproportionally bias 
mean estimates (N = 4). Sex, education level (low-, middle-, high-educated), perceived health status (self-report 
on a scale from 1–10), depression, anxiety, stress (DASS-21), illness symptoms (SCQ), smoking status (never-, 
ex-, current-smoker) and alcohol intake (units per week) were included as covariates and yielded virtually identi-
cal results. Variables were Z-transformed before analysis yielding standardised regression coefficients.
IL-6 analysis. A log10 transformation was applied to IL-6 data due to the skewed distribution of raw values; correla-
tional and partial correlation analyses were used to adjust for effects of other variables (for example, when assessing 
the relation between BMI and inflammation, we adjusted for age). Missing values (N = 5, 4 = young high BMI, 
1 = old high BMI) and extreme plasma IL-6 concentrations (>6 pg/ml) (N = 4, 3 = old low BMI, 1 = young high 
BMI) were replaced by group mean values. Repeating the main IL-6 analyses (Spearman correlations and ANOVAs) 
without replacement of IL-6 values produced similar results (see Supplementary information Table S3)99.
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The dataset of this article is accessible on reasonable request from the corresponding author.
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